/Investor DB

SR One Capital Management — 2015 Investments

1 investments dated 2015 · listed companies and verified rows first · show all

Trivasculartrivascular.comin𝕏Aug 2015acquired by EndologixSEC filingmedium confidence

Endologix develops medical devices and therapies for treating vascular disease, focusing on interventions such as EVAR (endovascular aneurysm repair) procedures.

HardwareHealthtechMedical DevicesSanta Rosa, US

Michael V. Chobotov(Executive Officer)inSHARI L. O'QUINN(Executive Officer)inMichael R. Kramer(Executive Officer)KIMBERLEY ELTING(Executive Officer)CHRISTOPHER CHAVEZ(Executive Officer, Director)VIVEK K. JAYARAMAN(Executive Officer)in

Board seatJake Nunn· per SEC Form D · $10M raise · filed Aug 2015

Co-investors415 CapitalKaiser Permanente VenturesNew Enterprise Associates (NEA)Deerfield Management Company

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.